Buy HCA stocks now with Interactive Brokers – the most advanced investment platform
- Performance
- Key stats
- Financials
- US politician trades
HCA stock trades by the US Senators and Representatives
In the last 12 months Finbold has discovered a total of 1 HCA trades made by 1 politicians. The the same period there was a total of 1 buy trades amounting to $1K - $15K , and 0 sell trades . Based on this information, it appears that 100.00% of the total politicians preferred to buy HCA Healthcare, Inc. stock, while none of the politicians preferred to sell HCA Healthcare, Inc. stock.
The largest recorded HCA stock trade by the US politician in the last 12 months was made by Jared Moskowitz , with a disclosed amount of between $1K - $15K .
HCA stock does not seem to have any one politician who would have done more than one HCA Healthcare, Inc. stock trade in the last 12 months.
Percentage
July 2025
Senator | Action | Amount | Date | Owner | Type |
---|---|---|---|---|---|
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Unlock All Transactions As They Come
Upgrade now to access all U.S. politician trades for this and other stocks. Get the latest signals as they come.
June 2025
Name | Action | Traded at | Amount | |
---|---|---|---|---|
Jared MoskowitzCongressman |
Purchase |
May 15
June 30
|
$1K - $15K |
Signal Details
Jared MoskowitzCongressman
Action
Purchase
Traded at
May 15
Disclosed at
June 30
Amount
1K - $15K
Owner
|
Methodology:
For trading activity of US Members of Congress, we collect data from the Financial Disclosures website. For US Senate trading activity, the data is collected from the United States Senate Financial Disclosures (eFD) website.
The price change since the date of disclosure is calculated by comparing the stock's closing price on the date of the disclosure to the current price of the asset.